| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 764,183 | 923,493 | 946,962 | 879,034 | | Cost of Revenue | 268,512 | 304,270 | 307,579 | 289,281 | | | Gross Profit | 495,671 | 619,223 | 639,383 | 589,753 | | | Operating Expenses | | Research Development | 185,400 | 180,134 | 194,014 | 186,357 | | Selling General and Administrative | 220,454 | 244,025 | 238,223 | 225,947 | | Non Recurring | 4,229 | 4,979 |
-
| 9,000 | | Others | 4,390 | 211 | 5,190 | 7,999 | | | | Total Operating Expenses | 414,473 | 429,349 |
-
| 429,303 | | | | Operating Income or Loss | 81,198 | 189,874 | 201,956 | 160,450 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 264 | (6,600) | 9,740 | 13,187 | | Earnings Before Interest And Taxes | 81,462 | 184,773 | 211,696 | 172,138 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 81,462 | 184,773 | 211,696 | 172,138 | | Income Tax Expense | 85,922 | 52,297 | 63,188 | 51,728 | | Minority Interest |
-
| 1,499 | (1,499) |
-
| | | | Net Income From Continuing Ops | (4,460) | 132,476 | 148,508 | 120,410 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,460) | 132,476 | 148,508 | 120,410 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,460) | $132,476 | $148,508 | $120,410 |
|
0.45% Nasdaq 
0.20%
Income Statement
